苯甲酸钠
化学
水溶液
无水的
色谱法
柠檬酸
奥司他韦
防腐剂
化学稳定性
草酸钠
柠檬酸钠
核化学
钠
有机化学
生物化学
医学
疾病
2019年冠状病毒病(COVID-19)
病理
传染病(医学专业)
作者
Albert Kamanyi,J Bockshorn
出处
期刊:Die Pharmazie
[Q26794415]
日期:2007-09-01
卷期号:62 (9): 678-82
被引量:5
摘要
The stability of oseltamivir in oral aqueous solutions containing the preservative sodium benzoate was studied by a stability indicating HPLC-method. The separation was achieved on a RP-18 ec column using a gradient of mobile phase A (aqueous solution of 50 mM ammonium acetate) and mobile phase B (60% (v/v) acetonitrile/40% (v/v) mobile phase A). The assay was subsequently validated according to the ICH guideline Q2(R1). The extemporaneously prepared "Oseltamivir Oral Solution 15 mg/ml for Adults or for Children" (NRF 31.2.) according to the German National Formulary ("Neues Rezeptur-Formularium") was stable for 84 days if stored under refrigeration. After storage at 25 degrees C the content of oseltamivir decreased to 98.4%. Considering the toxicological limit of 0.5% of the 5-acetylamino derivative (the so-called isomer I) the solution is stable for 46 days. Oseltamivir was less stable in a solution prepared with potable water instead of purified water. Due to an increasing pH the stability of this solution decreased to 14 days. Furthermore a white precipitate of mainly calcium phosphate was observed. The addition of 0.1% anhydrous citric acid avoided these problems and improved the stability of the solution prepared with potable water to 63 days. Sodium benzoate was stable in all oral solutions tested.
科研通智能强力驱动
Strongly Powered by AbleSci AI